Search research articles
Contact Us
Filters
Showing results (141-150 of 213) with videos related to
Page
of 22
Sort By:
Journal of the American College of Cardiology
|
January 6, 2026
Using Artificial Intelligence to Adjudicate Major Adverse Cardiovascular Events in Clinical Trials
Pablo M Marti-Castellote, Samarra Badrouchi, Brian Claggett, et al.
JAMA Internal Medicine
|
February 27, 2018
Effectiveness of an Intervention Supporting Shared Decision Making for Destination Therapy Left Ventricular Assist Device: The DECIDE-LVAD Randomized Clinical Trial
Larry A Allen, Colleen K McIlvennan, Jocelyn S Thompson, et al.
Circulation. Heart Failure
|
May 1, 2023
Prognostic Importance of NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) Following High-Risk Myocardial Infarction in the PARADISE-MI Trial
Karola S Jering, Brian L Claggett, Marc A Pfeffer, et al.
Journal of Diabetes Research
|
January 17, 2019
Retinopathy, Neuropathy, and Subsequent Cardiovascular Events in Patients with Type 2 Diabetes and Acute Coronary Syndrome in the ELIXA: The Importance of Disease Duration
Jelena P Seferovic, Rhonda Bentley-Lewis, Brian Claggett, et al.
European Journal of Heart Failure
|
November 17, 2022
Health-related quality of life outcomes in PARAGON-HF
Alvin Chandra, Carisi A Polanczyk, Brian L Claggett, et al.
Journal of the American College of Cardiology
|
March 5, 2021
Spironolactone in Patients With Heart Failure, Preserved Ejection Fraction, and Worsening Renal Function
Iris E Beldhuis, Peder L Myhre, Michael Bristow, et al.
Circulation. Heart Failure
|
October 22, 2021
Association of Hyper-Polypharmacy With Clinical Outcomes in Heart Failure With Preserved Ejection Fraction
Masatoshi Minamisawa, Brian Claggett, Kota Suzuki, et al.
European Journal of Heart Failure
|
September 2, 2022
Sacubitril/valsartan versus ramipril for patients with acute myocardial infarction: win-ratio analysis of the PARADISE-MI trial
Otavio Berwanger, Marc Pfeffer, Brian Claggett, et al.
JACC. Heart Failure
|
May 5, 2018
African Americans Are Less Likely to Receive Care by a Cardiologist During an Intensive Care Unit Admission for Heart Failure
Khadijah Breathett, Wenhui G Liu, Larry A Allen, et al.
The New England Journal of Medicine
|
December 3, 2015
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
Marc A Pfeffer, Brian Claggett, Rafael Diaz, et al.
Page
of 22
Search research articles
Search
Showing results (141-150 of 213) with videos related to
Sort By:
Page
of 22
Journal of the American College of Cardiology
|
January 6, 2026
Using Artificial Intelligence to Adjudicate Major Adverse Cardiovascular Events in Clinical Trials
Pablo M Marti-Castellote, Samarra Badrouchi, Brian Claggett, et al.
JAMA Internal Medicine
|
February 27, 2018
Effectiveness of an Intervention Supporting Shared Decision Making for Destination Therapy Left Ventricular Assist Device: The DECIDE-LVAD Randomized Clinical Trial
Larry A Allen, Colleen K McIlvennan, Jocelyn S Thompson, et al.
Circulation. Heart Failure
|
May 1, 2023
Prognostic Importance of NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) Following High-Risk Myocardial Infarction in the PARADISE-MI Trial
Karola S Jering, Brian L Claggett, Marc A Pfeffer, et al.
Journal of Diabetes Research
|
January 17, 2019
Retinopathy, Neuropathy, and Subsequent Cardiovascular Events in Patients with Type 2 Diabetes and Acute Coronary Syndrome in the ELIXA: The Importance of Disease Duration
Jelena P Seferovic, Rhonda Bentley-Lewis, Brian Claggett, et al.
European Journal of Heart Failure
|
November 17, 2022
Health-related quality of life outcomes in PARAGON-HF
Alvin Chandra, Carisi A Polanczyk, Brian L Claggett, et al.
Journal of the American College of Cardiology
|
March 5, 2021
Spironolactone in Patients With Heart Failure, Preserved Ejection Fraction, and Worsening Renal Function
Iris E Beldhuis, Peder L Myhre, Michael Bristow, et al.
Circulation. Heart Failure
|
October 22, 2021
Association of Hyper-Polypharmacy With Clinical Outcomes in Heart Failure With Preserved Ejection Fraction
Masatoshi Minamisawa, Brian Claggett, Kota Suzuki, et al.
European Journal of Heart Failure
|
September 2, 2022
Sacubitril/valsartan versus ramipril for patients with acute myocardial infarction: win-ratio analysis of the PARADISE-MI trial
Otavio Berwanger, Marc Pfeffer, Brian Claggett, et al.
JACC. Heart Failure
|
May 5, 2018
African Americans Are Less Likely to Receive Care by a Cardiologist During an Intensive Care Unit Admission for Heart Failure
Khadijah Breathett, Wenhui G Liu, Larry A Allen, et al.
The New England Journal of Medicine
|
December 3, 2015
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
Marc A Pfeffer, Brian Claggett, Rafael Diaz, et al.
Page
of 22